MicroRNA-940 inhibits glioma cells proliferation and cell cycle progression by targeting CKS1

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Glioblastoma (GBM) is an aggressive brain tumor with poor patient outcomes.
• MicroRNAs (miRNAs) play significant roles in GBM initiation and progression.
• The role of miR-940 in GBM remains largely unexplored.

Purpose of the Study:

• To investigate the expression and function of miR-940 in glioblastoma.
• To identify potential molecular targets of miR-940 in GBM.
• To explore the diagnostic and prognostic implications of the miR-940/CKS1 axis in GBM.

Main Methods:

• Quantitative analysis of miR-940 expression in GBM cells and tissues.
• In vitro studies assessing the impact of miR-940 on GBM cell proliferation and cell cycle.
• In vivo tumor xenograft models to evaluate miR-940's effect on tumor growth.
• Target validation experiments to confirm CKS1 as a miR-940 target.
• Correlation analysis between miR-940 and CKS1 levels in patient samples.

Main Results:

• miR-940 expression was significantly downregulated in GBM cells and tissues.
• Restoring miR-940 inhibited GBM cell proliferation and suppressed tumor growth in vivo, reducing Ki67 expression.
• CKS1 was identified as a direct target of miR-940; its knockdown mimicked miR-940's tumor-suppressive effects.
• Re-expression of CKS1 rescued the inhibitory effects of miR-940 on GBM cells.
• A negative correlation was observed between miR-940 and CKS1 mRNA levels in gliomas.

Conclusions:

• miR-940 acts as a tumor suppressor in glioblastoma.
• The miR-940/CKS1 signaling pathway is critical for GBM progression.
• This pathway presents a potential novel target for GBM diagnosis and therapy.